Byram Bridle discusses the potential of Ivermectin and Fenbendazole in treating cancer,

Byram Bridle discusses the potential of Ivermectin and Fenbendazole in treating cancer, emphasizing that while early research shows promise, the lack of profit from these cheap, off-patent drugs prevents big pharma from funding necessary trials.

He calls for government investment in research to explore these treatments further.

Bridle also highlights the cancer industry's focus on lifelong, expensive treatments rather than finding cures, driven by profit motives.